Lonza, a global contract development and manufacturing organization, to acquire the CDMO business of Merck ...
Illumina has announced it has been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a coho...
QIAGEN has announced that its QIAsprint Connect and QIAseq FX DNA Library Kit will support automated DNA extraction and ...
The Asia Pacific One Health Initiative (APOHI) has been launched in Singapore to strengthen regional preparedness agains...
A new Singapore study found that around one in six (16.7%) higher-risk patients with hormone receptor-positive (HR+), HE...
Samsung Biologics reported third-quarter revenue of KRW 1.49 trillion and operating profit of KRW 640 billion, supported...
Shionogi and F2G have reported detailed results from the global Phase 3 OASIS study evaluating investigational oral anti...
Andelyn Biosciences (“Andelyn”), a leading US-based patient-focused cell and gene therapy Contract Developme...
Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organisations, has announced the...
Cell and gene therapies may now be moving faster than the manufacturing networks built to deliver them. The Alliance of...
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company advancing blood- and cell-based therapies ...
Fatty liver disease is commonly associated with obesity, yet a growing number of people with normal body weight develop ...
Vetter, a leading Contract Development and Manufacturing Organization (CDMO), continues to expand its commercial fill-an...
Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences,...
NUS Enterprise, the entrepreneurial heart of the National University of Singapore, has unveiled its next chapter as NUSX...
The 2026 CDISC China Interchange has brought clinical research data specialists and industry stakeholders together in Sh...
Asia-Pacific is moving from being viewed primarily as a later-stage commercial market to becoming a more important sourc...
The global CDMO market is moving beyond the era when manufacturing capacity alone defined competitive ...
ADCs continue to represent a major growth area for drug developers, with the market projected to reach $69B by 20291. As...
As biotech innovation accelerates, Asia emerges as an increasingly important hub, driv...
As the pharmaceutical industry advances towards increasingly complex, poorly soluble drug candidates, formulation has ...
SGS has acquired CMIC, INC., a specialised bioanalytical testing services provider based in Chicago, Illinois, strengthe...
LabConnect, a leading provider of technology-driven central laboratory services and functional service provider sol...
Offering scalable quality grades from Research to GMP, PlasmidFactory supports advanced gene-based innovations worldwide...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...
